Results 31 to 40 of about 76,328,651 (141)

Regulation of Receptors Siglec-11 and Siglec-15 by MicroRNAs and their Overall Effect on Glioblastoma [PDF]

open access: yes, 2022
Introduction: Glioblastoma is a fast growing and aggressive type of brain tumour. It is the most common type of brain tumour in adults. Although there are developments in current therapies, patient outcomes remain poor.
Al-Azzawi, Dema
core   +1 more source

Siglec-15-induced autophagy promotes invasion and metastasis of human osteosarcoma cells by activating the epithelial–mesenchymal transition and Beclin-1/ATG14 pathway

open access: yesCell & Bioscience, 2022
Background Pulmonary metastasis is the main cause of poor prognosis in osteosarcoma. Sialic acid-bound immunoglobulin lectin 15 (Siglec-15) has been demonstrated to be obviously correlated with pulmonary metastasis in osteosarcoma patients.
Bingxin Zheng   +10 more
doaj   +1 more source

Anti-Siglec-15 antibody suppresses bone resorption by inhibiting osteoclast multinucleation without attenuating bone formation [PDF]

open access: yes, 2021
Tsukazaki H., Kikuta J., Ao T., et al. Anti-Siglec-15 antibody suppresses bone resorption by inhibiting osteoclast multinucleation without attenuating bone formation.
Kikuta, Junichi   +9 more
core   +2 more sources

Comprehensive Analysis of SIGLEC-15 and PD-L1 Expression Identifies Distinct Prognostic Profiles in Gastric Cancer. [PDF]

open access: yesInt J Mol Sci
Gastric cancer remains a major global health burden, with limited response rates to current immunotherapies targeting the programmed death-ligand 1 (PD-1/PD-L1) axis.
Cozac-Szőke AR   +13 more
europepmc   +2 more sources

Siglec-9 blocking antibody characterization.

open access: yes, 2021
(A) Binding ELISA of anti-Siglec-9 antibody. Recombinant human Siglec-9 protein was used in ELISA to assess the antigen-specific binding of the Siglec-9 blocking antibody. His-tag protein was used as a negative control.
Han Xiao (373894)   +16 more
core   +1 more source

Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases

open access: yesJournal of Biomedical Science, 2020
Siglec-15 is a member of the Siglec family of glycan-recognition proteins, primarily expressed on a subset of myeloid cells. Siglec-15 has been known to be involved in osteoclast differentiation, and is considered to be a potential therapeutic target for
Takashi Angata
doaj   +1 more source

An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion

open access: yesBone Research, 2021
Osteoporosis (OP) is a common age-related disease characterized by a deterioration of bone mass and structure that predisposes patients to fragility fractures.
Gehua Zhen   +11 more
doaj   +1 more source

Siglec-9+ CD56dim NK cells express CD7.

open access: yes, 2021
Fresh human PBMCs from an HIV-negative donor were stained for CD3, CD56, CD7, and Siglec-9. The majority of Siglec-9+ CD56dim NK cells express CD7, decreasing the chance that these cells are monocytes. FMO = Fluorescence Minus One. (EPS)
Han Xiao (373894)   +16 more
core   +1 more source

Siglec-9+ CD56dim cells exhibit lower cytotoxicity towards K562 cancer cells compared to Siglec-9- CD56dim.

open access: yes, 2021
Cytotoxicity was assessed using NK degranulation and IFNγ production (E: T = 4:1). Total NK cells were gated on Siglec-9+ or Siglec-9- CD56dim NK cell subsets.
Han Xiao (373894)   +16 more
core   +1 more source

Siglec-E promotes β2-integrin-dependent NADPH oxidase activation to suppress neutrophil recruitment to the lung [PDF]

open access: yes, 2014
Siglec-E is a sialic acid-binding Ig-like lectin expressed on murine myeloid cells. It has recently been shown to function as a negative regulator of ß2-integrin-dependent neutrophil recruitment to the lung following exposure to lipopolysaccharide (LPS).
Hegde, Vikas   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy